Canada Life’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.27M Sell
70,525
-1,305
-2% -$48.3K ﹤0.01% 1115
2025
Q4
$3.02M Sell
71,830
-16,486
-19% -$665K 0.01% 981
2025
Q3
$2.97M Buy
88,316
+60,125
+213% +$1.72M ﹤0.01% 1056
2025
Q2
$762K Buy
28,191
+182
+0.6% +$5.27K ﹤0.01% 1507
2025
Q1
$832K Buy
28,009
+2,792
+11% +$106K ﹤0.01% 1486
2024
Q4
$997K Buy
25,217
+1,395
+6% +$52.8K ﹤0.01% 1465
2024
Q3
$812K Buy
23,822
+3,560
+18% +$100K ﹤0.01% 1563
2024
Q2
$439K Buy
20,262
+12,064
+147% +$254K ﹤0.01% 1700
2024
Q1
$182K Buy
8,198
+530
+7% +$12.9K ﹤0.01% 1845
2023
Q4
$210K Sell
7,668
-506
-6% -$12.2K ﹤0.01% 1839
2023
Q3
$183K Buy
8,174
+3,200
+64% +$82.3K ﹤0.01% 1874
2023
Q2
$127K Sell
4,974
-403
-7% -$9.77K ﹤0.01% 1893
2023
Q1
$120K Buy
5,377
+169
+3% +$4.08K ﹤0.01% 1955
2022
Q4
$124K Buy
5,208
+381
+8% +$8.85K ﹤0.01% 1949
2022
Q3
$80K Buy
4,827
+234
+5% +$5.26K ﹤0.01% 2026
2022
Q2
$91K Buy
4,593
+250
+6% +$5.05K ﹤0.01% 1937
2022
Q1
$127K Buy
4,343
+216
+5% +$6.18K ﹤0.01% 1949
2021
Q4
$170K Buy
4,127
+211
+5% +$9.32K ﹤0.01% 1899
2021
Q3
$183K Hold
3,916
﹤0.01% 1919
2021
Q2
$156K Hold
3,916
﹤0.01% 1989
2021
Q1
$209K Buy
3,916
+361
+10% +$20.8K ﹤0.01% 1940
2020
Q4
$174K Hold
3,555
﹤0.01% 2000
2020
Q3
$115K Hold
3,555
﹤0.01% 2014
2020
Q2
$92K Hold
3,555
﹤0.01% 2061
2020
Q1
$87K Hold
3,555
﹤0.01% 2010
2019
Q4
$98K Buy
+3,555
New +$92K ﹤0.01% 2075
2019
Q3
Sell
-3,757
Closed -$107K 2242
2019
Q2
$107K Buy
+3,757
New +$93.8K ﹤0.01% 2201

Other funds holding VCYT

Canada Life's VCYT Position: Q1 2026 in Review

Canada Life reduced its Veracyte (VCYT) stake by 1.8% in Q1 2026, selling an estimated $48.3K and leaving 70,525 shares worth $2.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1115.

Canada Life first reported a position in VCYT in Q2 2019 and has held it in 27 quarters since. The position peaked at $3.02M in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Canada Life held 70,525 shares of Veracyte worth $2.27M as of Q1 2026.
  • Canada Life sold 1,305 Veracyte shares in Q1 2026, an estimated $48.3K.
  • Veracyte made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1115 holding.
  • Canada Life first reported a position in Veracyte in Q2 2019 and has held it in 27 quarters since.
  • Canada Life's Veracyte position peaked at $3.02M in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.